07:00 , Jul 15, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Multiple myeloma (MM) Killer cell immunoglobulin-like receptor three domains short cytoplasmic tail 1 (KIR3DS1; CD158E2); killer cell immunoglobulin-like...